New Delhi, March 24 The initial public offering of Sai Parenteral's Ltd, a diversified pharmaceutical formulation company, received 4% subscription on the first day of bidding on Tuesday.According to NSE data, the IPO received bids for 3,35,350 shares against 75,22,486 shares on offer.The...
capital markets
contractdevelopmentandmanufacturingorganization
equity shares
global formulations
india
initial public offering
injectable products
investment
ipo subscription
new delhi
oral solid dosage formulations
pharmaceutical formulation
price band
public offering
sai parenteral